Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemo OrganicBOM:524590 29 PS Ratio is 7.07 as of Sep. 04, 2026, which is 87% below its 10-year median of 56.52. GuruFocus rates BOM:524590 with a GF Score™ of 29/100. The stock has 7 warning signs investors should review. Among 533 Conglomerates companies, Hemo Organic ranks worse than 91.37% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Hemo Organic's share price is ₹18.91.
Hemo Organic's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹2.68. Hence, Hemo Organic's PS Ratio for today is 7.07.
The historical rank and industry rank for Hemo Organic's PS Ratio or its related term are showing as below:
BOM:524590'
s PS Ratio Range Over the Past 10 Years
Min: 1.16 Med: 56.52 Max: 3728.95
Current: 7.07
During the past 13 years, Hemo Organic's highest PS Ratio was 3728.95. The lowest was 1.16. And the median was 56.52.
BOM:524590's PS Ratio is ranked worse than 91.37% of 533
companies
in the Conglomerates industry
Industry Median: 0.9
vs BOM:524590: 7.07
Hemo Organic Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Hemo Organic was -61.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 475.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 240.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.50% per year.
During the past 13 years, Hemo Organic's highest 3-Year average Revenue per Share Growth Rate was 602.20% per year. The lowest was -73.60% per year. And the median was -20.85% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Hemo Organic PS Ratio Related Terms
Hemo Organic PS Ratio Historical Data
* Premium members only.
The historical data trend for Hemo Organic's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Hemo Organic's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemo Organic PS Ratio vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Hemo Organic's PS Ratio distribution charts can be found below:
* The bar in red indicates where Hemo Organic's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Hemo Organic's PS Ratio for today is calculated as
Hemo Organic's Share Price of today is ₹18.91. Hemo Organic's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.68.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Hemo Organic (BOM:524590) has a PS Ratio of 7.07 as of Sep. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hemo Organic and its competitors. This is 87% below median its historical median of 56.52. Over the past decade, Hemo Organic's PS Ratio has ranged from 1.16 to 3,728.95. According to the industry distribution chart, Hemo Organic ranks #487 out of 533 companies in the Conglomerates industry, placing it in the top 91.4%.
Is Hemo Organic's PS Ratio too high?
Hemo Organic's current PS Ratio of 7.07 is 87% below median its 10-year median of 56.52. Over the past 10 years, this metric has ranged from a low of 1.16 to a high of 3,728.95. The Conglomerates industry median PS Ratio is 0.90. Hemo Organic's value of 7.07 is 685.6% above this industry median. Based on the distribution chart, Hemo Organic ranks #487 out of 533 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, Hemo Organic has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Hemo Organic's PS Ratio compare to MMM and HON?
According to the Conglomerates industry distribution chart, Hemo Organic ranks #487 out of 533 companies for PS Ratio. This places Hemo Organic in the lower half of its industry. The industry median PS Ratio is 0.90. Hemo Organic's value of 7.07 is 685.6% above this benchmark. Historically, Hemo Organic's own PS Ratio has ranged from 1.16 to 3,728.95 over the past decade. While the company's 10-year median is 56.52 vs. the industry median of 0.90, Hemo Organic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Conglomerates company?
The median PS Ratio among Conglomerates companies is 0.90, based on 533 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemo Organic's current PS Ratio of 7.07 is 685.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hemo Organic and its competitors. For the Conglomerates industry, the median PS Ratio is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemo Organic's current PS Ratio is 7.07, which is 87% below median its own 10-year median of 56.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemo Organic stock overvalued right now?
Hemo Organic (BOM:524590) has a current PS Ratio of 7.07. The current PS Ratio is 7.07, which is 87% below median its 10-year median of 56.52 and 685.6% above the Conglomerates industry median of 0.90. Hemo Organic's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Hemo Organic (BOM:524590), the current PS Ratio is 7.07 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hemo Organic Ltd is mainly focused on trading and distribution, particularly in rice and textiles. The company buys, sells, imports, exports, and distributes agricultural commodities such as wheat, rice, maize, vegetables, and fruits at both retail and wholesale levels, maintaining high standards across domestic and international markets. Its portfolio includes wheat, rice, maize, vegetables like capsicum, tomato, green chili, onion, and potato, as well as fruits including apple, red dragon fruit, sweet lime, and pomegranate.
29GF Score
Get the complete analysis for BOM:524590
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524590 has been successfully added to your 
